![]() |
Figure 4: Analysis of silver nanoparticles in platelet aggregation test. Silver
nanoparticles with nominal size of 20 nm (A), 40 nm (B), 60 nm (C) and 80
nm (D), untreated or sterilized with various methods, were evaluated for their
potential effects on the cellular component of the blood coagulation cascade.
For each nanoparticle formulation, three independent samples were prepared
and analyzed in duplicate (%CV < 20). Each bar represents the mean response
of these three independent samples plus SD. |